GR3025518T3 - Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus - Google Patents

Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus

Info

Publication number
GR3025518T3
GR3025518T3 GR970403167T GR970403167T GR3025518T3 GR 3025518 T3 GR3025518 T3 GR 3025518T3 GR 970403167 T GR970403167 T GR 970403167T GR 970403167 T GR970403167 T GR 970403167T GR 3025518 T3 GR3025518 T3 GR 3025518T3
Authority
GR
Greece
Prior art keywords
manufacture
desoxynojirimycin
virus
inhibiting hiv
butyl derivative
Prior art date
Application number
GR970403167T
Other languages
English (en)
Inventor
Raymond Allen Dwek
George William John Fleet
Thomas William Rademacher
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/248,461 external-priority patent/US4849430A/en
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of GR3025518T3 publication Critical patent/GR3025518T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR970403167T 1987-12-21 1997-11-26 Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus GR3025518T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13622487A 1987-12-21 1987-12-21
US16606588A 1988-03-09 1988-03-09
US07/248,461 US4849430A (en) 1988-03-09 1988-09-23 Method of inhibiting virus

Publications (1)

Publication Number Publication Date
GR3025518T3 true GR3025518T3 (en) 1998-02-27

Family

ID=27384837

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403167T GR3025518T3 (en) 1987-12-21 1997-11-26 Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus

Country Status (15)

Country Link
EP (1) EP0324328B1 (el)
JP (1) JPH01203326A (el)
KR (1) KR910010020B1 (el)
AT (1) ATE159427T1 (el)
AU (1) AU605661B2 (el)
CA (1) CA1316459C (el)
DE (1) DE3856052T2 (el)
DK (1) DK175094B1 (el)
ES (1) ES2108680T3 (el)
GR (1) GR3025518T3 (el)
IE (1) IE81173B1 (el)
IL (1) IL88740A (el)
NZ (1) NZ227411A (el)
OA (1) OA09027A (el)
PT (1) PT89266B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
PT1030839E (pt) 1997-11-10 2004-05-31 Searle & Co Utilizacao de iminoacucares para tratar a resistencia a multifarmacos
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
DE69932154T2 (de) 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
ATE402701T1 (de) 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
CN115806913B (zh) * 2022-10-21 2023-09-08 福建省农业科学院植物保护研究所 野尻链霉菌（Streptomyces nojiriensis）菌株9-13及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
JPS5311800A (en) * 1976-07-20 1978-02-02 Asahi Chemical Ind Method of well preserving and transporting live fish and apparatus therefor
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel

Also Published As

Publication number Publication date
NZ227411A (en) 1997-03-24
ES2108680T3 (es) 1998-01-01
JPH0521891B2 (el) 1993-03-25
JPH01203326A (ja) 1989-08-16
DE3856052T2 (de) 1998-02-19
ATE159427T1 (de) 1997-11-15
EP0324328A2 (en) 1989-07-19
KR910010020B1 (ko) 1991-12-10
PT89266A (pt) 1989-12-29
DK175094B1 (da) 2004-06-01
IL88740A (en) 1993-01-31
AU2706788A (en) 1989-06-22
KR890009401A (ko) 1989-08-01
EP0324328A3 (en) 1990-06-20
EP0324328B1 (en) 1997-10-22
CA1316459C (en) 1993-04-20
IL88740A0 (en) 1989-07-31
PT89266B (pt) 1993-11-30
IE883793L (en) 1989-06-21
IE81173B1 (en) 2000-05-31
DK707988D0 (da) 1988-12-20
AU605661B2 (en) 1991-01-17
DK707988A (da) 1989-06-22
OA09027A (fr) 1991-03-31
DE3856052D1 (de) 1997-11-27

Similar Documents

Publication Publication Date Title
ZA883602B (en) Medicament
TJ249B (en) 1,3-Oxathiolane nucleoside analogues their use
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
GR3021845T3 (en) Use of N-butyl-deoxynojirimycin in the treatment of herpes
UA41355C2 (uk) Засіб для лікування нейро-сніду
EP0550006A3 (en) Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
WO1986006960A3 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
GR3015107T3 (en) Use of zofenopril for the preparation of drugs against rheumatoid arthritis.
CY2337B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection.
WO1996027378A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ZM7288A1 (en) Treatment of diseases caused by retroviruses
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA
GR3006610T3 (el)
ZA892712B (en) Oral pharmaceutical for the once-a-day treatment of hypertonia with diltiazem-hydrochloride